RE: Good example of how a deal is brokered3 Sep 2020 11:30
There is a downside to this, well, for some at least. Tim and the shareholders have to be willing to walk away from a bad deal. We can only do that with some funding behind us. The 737 milestones, if we even get them will not cover P1 trials for 2 compounds. Tim knows the worth of these compounds, as do the shareholders but big pharma can easily sit this out until we are down to our last few pence. I believe we can get deals worth 100's of million or TYK2 but the shareholders have to understand what game we are playing and the need to raise funds if needed. I'm not sure this post will go down well, let alone the possibility of raising.